| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/18/2001 | US6290970 Transferrin receptor protein of Moraxella |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290967 Stabilizers for lyophilized vaccines |
| 09/18/2001 | US6290966 Dim mutants of mycobacteria and use thereof |
| 09/18/2001 | US6290965 DNA encoding human papillomavirus type 6A |
| 09/18/2001 | US6290963 Anti-HIV compositions containing native and recombinant peptides |
| 09/18/2001 | US6290962 Urease-based vaccine and treatment for helicobacter infection |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |
| 09/18/2001 | US6290950 Mycosis vaccines |
| 09/18/2001 | US6290948 Using certain chemokines or biologically active fragments thereof alone or in conjunction with an anti-infective agent or hematopoietic maturing agent. |
| 09/18/2001 | US6290946 Administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. |
| 09/18/2001 | US6289892 Partial liquid breathing of fluorocarbons |
| 09/18/2001 | US6289745 High temperature insertion type flow element and mounting extension |
| 09/18/2001 | CA2045783C 9-purinyl phosphonic acid derivatives |
| 09/18/2001 | CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/13/2001 | WO2001066785A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066722A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066594A2 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 09/13/2001 | WO2001066569A1 Viral antigen and vaccine against isav (infectious salmon anaemia virus) |
| 09/13/2001 | WO2001066566A2 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066551A2 Azole compounds as therapeutic agents for fungal infections |
| 09/13/2001 | WO2001066550A2 Compounds for pdt |
| 09/13/2001 | WO2001066542A1 Pyridonecarboxylic acid derivatives |
| 09/13/2001 | WO2001066525A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | WO2001066519A2 Method for preparing pyrimidone derivatives with antifungal activity |
| 09/13/2001 | WO2001066159A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such |
| 09/13/2001 | WO2001066147A2 Antimicrobial compounds and formulations |
| 09/13/2001 | WO2001066145A1 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
| 09/13/2001 | WO2001066140A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | WO2001066138A2 Dna vaccines against poxviruses |
| 09/13/2001 | WO2001066137A1 Adenovirus formulations |
| 09/13/2001 | WO2001066132A2 Hiv immune adjuvant therapy |
| 09/13/2001 | WO2001066123A2 Composition consisting of phy906 and chemotherapeutic agents |
| 09/13/2001 | WO2001066112A1 Urease inhibitors |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001066100A2 Pharmaceutical composition |
| 09/13/2001 | WO2001066097A2 Active substance directed against microbes of the genus pseudomonas |
| 09/13/2001 | WO2001066089A2 Pharmaceutical compositions comprising cannabis |
| 09/13/2001 | WO2001066085A2 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 09/13/2001 | WO2001065949A1 Treatment of infection in animals |
| 09/13/2001 | WO2001045712A8 Combinations of medicaments for treating viral diseases |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | WO2001028498A3 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 09/13/2001 | WO2001028497A3 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 09/13/2001 | WO2001028492A3 Polyanhydrides with biologically active degradation products |
| 09/13/2001 | WO2001028338A3 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 09/13/2001 | WO2001009169A3 Cysteine protease inhibitors |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | WO2001005480A3 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 09/13/2001 | WO2001004282A3 Replication-competent anti-cancer vectors |
| 09/13/2001 | WO2001003744A3 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |
| 09/13/2001 | WO2000062795A3 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 09/13/2001 | WO1997042968A3 Administration of histamine for therapeutic purposes |
| 09/13/2001 | WO1997014683A3 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 09/13/2001 | US20010021758 Drugs, medical diagnosis |
| 09/13/2001 | US20010021693 Non-aqueous or oily injection formulation obtainable by in-situ preparation and stabilization of the free, unstable base of valnemulin; treating infectious diseases in livestock and domestic animals; storage stability |
| 09/13/2001 | US20010021516 An isolated nucleic acid molecule comprising a polynucleotide having nucleotide sequence atleast 95% identical to a sequence selected from a nucleotide sequence encoding a TRID polypeptide having specific amino acid sequence |
| 09/13/2001 | US20010021393 Antibodies from eggs immunized with urease of Helicobacter |
| 09/13/2001 | US20010021386 Salmonella vaccine |
| 09/13/2001 | US20010021385 Human papillomavirus vaccine with disassembled and reassembled virus-like particles |
| 09/13/2001 | US20010021383 Antibodies for diagnosis, therapy |
| 09/13/2001 | DE19963840A1 Zusammensetzung zum Vorbeugen und Behandeln von allergischen Erkrankungen A composition for preventing and treating allergic diseases |
| 09/13/2001 | DE10011081A1 Lacquer formulation for treating and preventing onychomycosis, comprising combination of systemic and topical antimycotic agents in film-forming polymer base |
| 09/13/2001 | DE10010512A1 Non-toxic antimicrobial agent for controlling Pseudomonas aeruginosa, comprising hydroxychavicol, especially used as disinfectant, preservative or drug for topical or oral administration |
| 09/13/2001 | CA2799545A1 Adenovirus formulations |
| 09/13/2001 | CA2403029A1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |
| 09/13/2001 | CA2402602A1 Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides |
| 09/13/2001 | CA2402466A1 Composition consisting of phy906 and chemotherapeutic agents |
| 09/13/2001 | CA2402433A1 Compounds for pdt |
| 09/13/2001 | CA2402345A1 Azole compounds as therapeutic agents for fungal infections |
| 09/13/2001 | CA2402211A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | CA2402024A1 Hiv immune adjuvant therapy |
| 09/13/2001 | CA2401549A1 G-protein coupled receptor related polypeptides |
| 09/13/2001 | CA2401541A1 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | CA2401454A1 G-protein coupled receptors |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2400628A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | CA2400527A1 Urease inhibitors |
| 09/13/2001 | CA2400410A1 Antimicrobial compounds and formulations |
| 09/13/2001 | CA2400401A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such |
| 09/13/2001 | CA2399943A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399921A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399913A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132466A1 Chicken anaemia viruses of low pathogenicity |
| 09/12/2001 | EP1132401A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 09/12/2001 | EP1132398A2 DNA sequence encoding the specific and antigenic outer membrane protein of salmonella typhi |
| 09/12/2001 | EP1132392A1 Ketolide antibiotics |
| 09/12/2001 | EP1132391A1 Process for the preparation of 3-sulfonyloxy-3-cephem compounds |
| 09/12/2001 | EP1131633A2 Hiv-specific t-cell induction |